Viatris Inc. VTRS | NASDAQ
$17.72
-$0.40 | -2.21%
SIGNAL:
|2026-09-22
|F&G 63
|RSI 60.3
|2026-09-22
|F&G 63
|RSI 60.3
Company Overview:
Market Cap:
$20.36B
Trailing PE:
N/A
FWD PE *:
7x
Payout Ratio (TTM):
—
52-Week Range:
$9.69 - $18.43
* Forward PE is based on street estimates.
10 Year VTRS Performance Metrics:
Total Return (with DRIP):
-43.4% (-5.53% CAGR)
Total Return (no DRIP):
-47.7% (-6.28% CAGR)
Share Price:
-53.5% (-7.37% CAGR)
Yield on Cost (with DRIP):
1.53%
Total Invested:
$10,000
Total Value (with DRIP):
$5,662
Total Return $ (with DRIP):
-$4,338
Dividend Increase:
9.1% (1.67% CAGR)
Dividend Yield (FWD):
2.71% ($0.48)
VTRS 10-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
VTRS Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
VTRS Price CAGR:1Y: 78.99%2Y: 23.54%5Y: 5.51%10Y: -7.37%
VTRS Dividend Charts
VTRS Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 1.67%10Y: 0.46%
VTRS Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Dividend to FCF Ratio CAGR:1Y: -48.57%2Y: -2.24%5Y: 0.00%10Y: 0.00%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
VTRS Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
VTRS Revenue CAGR:1Y: 4.88%2Y: -0.53%5Y: -3.88%10Y: 3.91%
VTRS EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS EBITDA CAGR:1Y: 37.83%2Y: 21.30%5Y: -9.29%10Y: 2.93%
VTRS Free Cash Flow CAGR:1Y: 94.44%2Y: 0.27%5Y: -6.74%10Y: 1.66%
VTRS Free Cash Flow / Share CAGR:1Y: 100.33%2Y: 2.55%5Y: -5.62%10Y: -6.28%
VTRS Operating Income CAGR:1Y: -68.37%2Y: 0.00%5Y: 0.00%10Y: -15.79%
VTRS Gross Profit CAGR:1Y: 9.27%2Y: -1.23%5Y: 1.87%10Y: 2.20%
VTRS Shares Outstanding CAGR:1Y: -0.83%2Y: -1.17%5Y: -0.76%10Y: 8.60%
VTRS Share Buybacks CAGR:1Y: -14.29%2Y: 0.00%5Y: 92.33%10Y: 38.44%
VTRS Stock-Based Comp CAGR:1Y: 4.31%2Y: 5.61%5Y: 4.54%10Y: 4.30%
VTRS Expenses CAGR:1Y: -2.40%2Y: -5.24%5Y: -12.49%10Y: -9.52%
VTRS Revenue CAGR:1Y: 4.88%2Y: -0.53%5Y: -3.88%10Y: 3.91%
VTRS Revenue CAGR:1Y: 4.88%2Y: -0.53%5Y: -3.88%10Y: 3.91%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
VTRS Actual Revenue CAGR:1Y: 4.88%2Y: -0.53%5Y: -3.88%10Y: 3.91%
VTRS Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Actual EBITDA CAGR:1Y: 37.83%2Y: 21.30%5Y: -9.29%10Y: 2.93%
Ratios, Profit Margins & Return on Capital:
VTRS Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Gross Profit Margin CAGR:1Y: 4.19%2Y: -0.71%5Y: 5.98%10Y: -1.64%
VTRS Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VTRS Price To Sales Ratio CAGR:1Y: 68.16%2Y: 21.66%5Y: 5.44%10Y: -5.35%
VTRS Return on Capital Employed CAGR:1Y: -97.05%2Y: 0.00%5Y: 0.00%10Y: -35.04%
VTRS Return on Invested Capital CAGR:1Y: 38.11%2Y: 0.00%5Y: 0.00%10Y: -34.56%
VTRS Dividends Info:
Annual Dividend:
$0.48
Forward Yield:
2.71%
Ex-Dividend Date:
2026-08-21
Lifetime Dividends / Share:
$4.19
VTRS Dividend History: Dates, Payments & Yield list
Below is a schedule of all VTRS dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 08/21/2026 | 08/24/2026 | $0.120 | 2.94% | 2.9% | $16.54 |
| 05/22/2026 | 05/25/2026 | $0.120 | 2.88% | 3.05% | $15.73 |
| 03/09/2026 | 03/11/2026 | $0.120 | 3.38% | 3.44% | $13.97 |
| 11/24/2025 | 11/26/2025 | $0.120 | 4.54% | 4.51% | $10.64 |
| 08/22/2025 | 08/25/2025 | $0.120 | 4.51% | 4.55% | $10.55 |
| 05/23/2025 | 05/26/2025 | $0.120 | 5.79% | 5.34% | $8.99 |
| 03/10/2025 | 03/12/2025 | $0.120 | 5.05% | 5.19% | $9.24 |
| 11/22/2024 | 11/25/2024 | $0.120 | 3.59% | 3.59% | $13.36 |
| 08/23/2024 | 08/26/2024 | $0.120 | 4.08% | 4.09% | $11.75 |
| 05/23/2024 | 05/27/2024 | $0.120 | 4.56% | 4.72% | $10.17 |
| 03/08/2024 | 03/11/2024 | $0.120 | 3.92% | 4.01% | $11.97 |
| 11/22/2023 | 11/24/2023 | $0.120 | 5.12% | 5.09% | $9.43 |
| 08/23/2023 | 08/25/2023 | $0.120 | 4.36% | 4.38% | $10.97 |
| 05/23/2023 | 05/25/2023 | $0.120 | 5.19% | 5.32% | $9.03 |
| 03/08/2023 | 03/10/2023 | $0.120 | 4.55% | 4.8% | $10.00 |
| 11/22/2022 | 12/16/2022 | $0.120 | 4.34% | 4.38% | $10.96 |
| 08/23/2022 | 09/16/2022 | $0.120 | 4.73% | 5.16% | $9.30 |
| 05/23/2022 | 06/16/2022 | $0.120 | 4.13% | 4.67% | $10.28 |
| 02/23/2022 | 03/16/2022 | $0.120 | 3.35% | 4.62% | $10.39 |
| 11/22/2021 | 12/16/2021 | $0.110 | 3.35% | 3.38% | $13.02 |
| 08/23/2021 | 09/16/2021 | $0.110 | 2.98% | 3.21% | $13.69 |
| 05/21/2021 | 06/16/2021 | $0.110 | 2.87% | 2.89% | $15.22 |
| 06/27/2007 | 07/16/2007 | $0.060 | 1.3% | 1.34% | $17.94 |
| 03/28/2007 | 04/16/2007 | $0.060 | 1.14% | 1.1% | $21.80 |
| 12/27/2006 | 01/16/2007 | $0.060 | 1.21% | 1.15% | $20.91 |
| 09/27/2006 | 10/16/2006 | $0.060 | 1.2% | 1.11% | $21.55 |
| 06/28/2006 | 07/14/2006 | $0.060 | 1.17% | 1.24% | $19.31 |
| 03/29/2006 | 04/17/2006 | $0.060 | 1% | 1.08% | $22.12 |
| 12/28/2005 | 01/13/2006 | $0.060 | 1.19% | 1.17% | $20.56 |
| 09/28/2005 | 10/17/2005 | $0.060 | 1.27% | 1.2% | $19.94 |
| 06/28/2005 | 07/15/2005 | $0.060 | 1.24% | 1.24% | $19.40 |
| 03/29/2005 | 04/15/2005 | $0.030 | 0.68% | 0.71% | $16.86 |
| 12/29/2004 | 01/14/2005 | $0.030 | 0.68% | 0.7% | $17.21 |
| 09/28/2004 | 10/15/2004 | $0.030 | 0.67% | 0.68% | $17.52 |
| 06/28/2004 | 07/15/2004 | $0.030 | 0.6% | 0.62% | $19.46 |
| 03/29/2004 | 04/15/2004 | $0.030 | 0.52% | 0.52% | $23.20 |
| 12/29/2003 | 01/15/2004 | $0.030 | 0.48% | 0.48% | $24.81 |
| 09/26/2003 | 10/15/2003 | $0.022 | 0.35% | 0.32% | $27.98 |
| 06/26/2003 | 07/15/2003 | $0.022 | 0.38% | 0.41% | $21.65 |
| 03/27/2003 | 04/15/2003 | $0.022 | 0.46% | 0.49% | $18.19 |
| 12/27/2002 | 01/15/2003 | $0.022 | 0.6% | 0.52% | $17.24 |
| 09/26/2002 | 10/15/2002 | $0.018 | 0.48% | 0.49% | $14.58 |
| 06/26/2002 | 07/15/2002 | $0.018 | 0.54% | 0.55% | $12.93 |
| 03/26/2002 | 04/15/2002 | $0.018 | 0.53% | 0.57% | $12.40 |
| 12/27/2001 | 01/15/2002 | $0.018 | 0.43% | 0.45% | $15.92 |
| 09/26/2001 | 10/15/2001 | $0.018 | 0.51% | 0.5% | $14.16 |
| 06/27/2001 | 07/16/2001 | $0.018 | 0.57% | 0.56% | $12.76 |
| 03/28/2001 | 04/16/2001 | $0.018 | 0.64% | 0.65% | $10.99 |
| 12/27/2000 | 01/15/2001 | $0.018 | 0.63% | 0.68% | $10.44 |
| 09/27/2000 | 10/16/2000 | $0.018 | 0.57% | 0.56% | $12.69 |
| 06/28/2000 | 07/14/2000 | $0.018 | 0.92% | 0.85% | $8.33 |
| 03/29/2000 | 04/17/2000 | $0.018 | 0.61% | 0.58% | $12.33 |
| 12/29/1999 | 01/14/2000 | $0.018 | 0.64% | 0.59% | $12.14 |
| 09/28/1999 | 10/15/1999 | $0.018 | 0.9% | 0.9% | $7.94 |
| 06/28/1999 | 07/15/1999 | $0.018 | 0.63% | 0.53% | $13.31 |
| 03/29/1999 | 04/15/1999 | $0.018 | 0.58% | 0.68% | $10.53 |
| 12/29/1998 | 01/15/1999 | $0.018 | 0.55% | 0.53% | $13.33 |
| 09/28/1998 | 10/15/1998 | $0.018 | 0.55% | 0.53% | $13.50 |
| 06/26/1998 | 07/15/1998 | $0.018 | 0.5% | 0.47% | $15.03 |
| 03/30/1998 | 04/15/1998 | $0.018 | 0.68% | 0.62% | $11.56 |
| 12/29/1997 | 01/15/1998 | $0.018 | 0.78% | 0.78% | $9.06 |
| 09/26/1997 | 10/15/1997 | $0.018 | 0.71% | 0.66% | $10.72 |
| 06/26/1997 | 07/15/1997 | $0.018 | 1.07% | 1% | $7.08 |
| 03/26/1997 | 04/15/1997 | $0.018 | 1.05% | 1.28% | $5.56 |
| 12/30/1996 | 01/15/1997 | $0.018 | 0.95% | 0.93% | $7.67 |
| 09/26/1996 | 10/15/1996 | $0.018 | 0.93% | 1.05% | $6.78 |
| 06/26/1996 | 07/15/1996 | $0.018 | 0.93% | 1.08% | $6.56 |
| 03/27/1996 | 04/15/1996 | $0.018 | 0.79% | 0.81% | $8.83 |
| 12/27/1995 | 01/15/1996 | $0.018 | 0.68% | 0.76% | $9.39 |
| 09/27/1995 | 10/13/1995 | $0.018 | 0.78% | 0.82% | $8.67 |
| 06/29/1995 | 07/14/1995 | $0.015 | 0.64% | 0.68% | $8.67 |
| 03/27/1995 | 04/13/1995 | $0.015 | 0.6% | 0.62% | $9.52 |
| 12/23/1994 | 12/28/1994 | $0.018 | 0.9% | 0.9% | $7.89 |
| 09/26/1994 | 09/28/1994 | $0.015 | 0.82% | 0.77% | $7.70 |
| 06/24/1994 | 06/29/1994 | $0.012 | 0.75% | 0.73% | $6.52 |
| 03/25/1994 | 03/30/1994 | $0.012 | 0.88% | 0.96% | $4.96 |
| 12/27/1993 | 12/29/1993 | $0.012 | 0.66% | 0.63% | $7.52 |
| 09/24/1993 | 09/29/1993 | $0.012 | 0.59% | 0.57% | $8.33 |
| 06/24/1993 | 06/28/1993 | $0.009 | 0.42% | 0.41% | $8.67 |
| 03/25/1993 | 03/29/1993 | $0.009 | 0.43% | 0.44% | $8.15 |
| 12/24/1992 | 12/28/1992 | $0.009 | 0.4% | 0.4% | $8.89 |
| 09/24/1992 | 09/28/1992 | $0.009 | 0.44% | 0.48% | $7.44 |
| 06/24/1992 | 06/26/1992 | $0.007 | 0.55% | 0.53% | $5.63 |
| 03/25/1992 | 03/27/1992 | $0.007 | 0.53% | 0.55% | $5.41 |
| 12/24/1991 | 12/26/1991 | $0.007 | 0.52% | 0.52% | $5.74 |
| 09/24/1991 | 09/26/1991 | $0.007 | 0.61% | 0.59% | $4.98 |
| 06/24/1991 | 06/26/1991 | $0.007 | 0.79% | 0.81% | $3.67 |
| 03/22/1991 | 03/27/1991 | $0.007 | 0.37% | 0.38% | $3.91 |
| 12/24/1990 | 12/26/1990 | $0.007 | 0.51% | 0.5% | $2.96 |
| 09/24/1990 | 10/15/1990 | $0.007 | 0.55% | 0.55% | $2.69 |
| 06/25/1990 | 07/16/1990 | $0.007 | 0.44% | 0.44% | $3.35 |
| 12/22/1989 | 01/15/1990 | $0.007 | 0.41% | 0.48% | $3.06 |
| 06/26/1989 | 07/17/1989 | $0.007 | 0.95% | 0.97% | $1.52 |
| 12/23/1988 | 01/16/1989 | $0.004 | 0.59% | 0.59% | $1.26 |
| 06/29/1988 | 07/15/1988 | $0.007 | 0.77% | 0.84% | $1.76 |
| 12/24/1987 | 01/15/1988 | $0.007 | 2.26% | 2.13% | $1.39 |
| 06/24/1987 | 07/15/1987 | $0.007 | 1.27% | 1.35% | $2.19 |
| 12/24/1986 | 01/15/1987 | $0.007 | 1.77% | 1.48% | $2.00 |
Projected Future Returns & Dividends for VTRS
Based on past 10-year performance, here are VTRS growth metrics:
Share price CAGR of -7.37%
Dividend CAGR of +1.67%
Using VTRS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| VTRS (DRIP) | VTRS - No DRIP | |
|---|---|---|
| Current Price | $17.72 | $17.72 |
| Start Shares | 564.33 | 564.33 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 862.74 | 564.33 |
| Dividends Payment | $0.14 | $0.14 |
| Annual Dividends | $489 | $320 |
| Yield on cost | 4.89% | 3.20% |
| Share Price | $8.24 | $8.24 |
| Total Dividends | $3,526 | $2,922 |
| Final Value | $7,106 | $7,570 |
Estimated Future Value + Dividends - VTRS
NOTE: Above numbers are our estimate based on VTRS's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Company Info
Viatris Inc. (VTRS) had its IPO on 1980-03-17, and is traded on NASDAQ stock exchange.
Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.
VTRS website: https://www.viatris.com
Get Full Access to All Reports with DRIPCalc PRO
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Loading signals…
DCF Model — VTRS
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $17.72
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
